FindTrial
Sign In

Interferon alfa-n1

DRUG5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Glaxo Wellcome

Conditions

HIV InfectionsSarcoma, Kaposi

Phase 1

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
CompletedNCT00001113
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Sarcoma, Kaposi
End: 1990-03-31Target: 48Updated: 2021-11-04
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
CompletedNCT00000725
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Sarcoma, Kaposi
End: 1990-02-28Target: 56Updated: 2021-11-03

Phase 2

A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection
CompletedNCT00002086
Glaxo WellcomeHIV Infections
Target: 256Updated: 2005-06-24

Unknown Phase

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
CompletedNCT00000647
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
End: 1994-12-31Target: 6Updated: 2021-10-27
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
CompletedNCT00000844
National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections
End: 2002-06-30Target: 560Updated: 2021-11-03